Befejeződött1. fázis
A Phase 1b Study of Imvotamab in Severe Systemic Lupus Erythematosus
Key facts
- Where
- Lodz, Lublin, Nadarzyn és Poznan, LengyelországSee the 5 sites
- Phase
- 1. fázis
Where in Lengyelország
- Samodzielny Publiczny Zaklad Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego W LodziLodz, LengyelországNo longer taking part
- Reumed Sp. z o.o.Lublin, LengyelországNo longer taking part
- NZOZ Lecznica MAK MED S CNadarzyn, LengyelországNo longer taking part
- Med Polonia Sp z o.o.Poznan, LengyelországNo longer taking part
- Reumedika Sp. z o.o.Poznan, LengyelországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- IGM Biosciences Inc.
- Trial code
- EU 2023-506499-29-00
- Record updated
- 2024. november 11.